Christenson ES, Ho WJ, Shu D, Durham JN, et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. Clin Cancer Res 2025 May 19. doi: 10.1158/1078-0432.CCR-25-0002.
PMID: 40388545